MARROSU, MARIA GIOVANNA
 Distribuzione geografica
Continente #
EU - Europa 410.471
NA - Nord America 23.482
AS - Asia 8.994
SA - Sud America 1.180
AF - Africa 194
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 22
Totale 444.368
Nazione #
IT - Italia 404.534
US - Stati Uniti d'America 23.205
SG - Singapore 3.524
CN - Cina 3.444
UA - Ucraina 1.823
SE - Svezia 1.107
BR - Brasile 931
FI - Finlandia 702
DE - Germania 670
GB - Regno Unito 661
VN - Vietnam 651
FR - Francia 501
HK - Hong Kong 305
IN - India 209
KR - Corea 176
CA - Canada 171
BD - Bangladesh 99
NL - Olanda 91
AR - Argentina 78
IQ - Iraq 75
RU - Federazione Russa 71
TR - Turchia 65
PK - Pakistan 61
JP - Giappone 57
MX - Messico 57
ZA - Sudafrica 49
EC - Ecuador 46
ES - Italia 46
MA - Marocco 43
PL - Polonia 43
BE - Belgio 42
AT - Austria 38
VE - Venezuela 37
ID - Indonesia 35
SA - Arabia Saudita 34
UZ - Uzbekistan 34
CO - Colombia 30
PH - Filippine 27
CL - Cile 25
IL - Israele 24
AU - Australia 21
EU - Europa 21
MY - Malesia 21
CZ - Repubblica Ceca 19
AZ - Azerbaigian 18
IR - Iran 18
JO - Giordania 17
DZ - Algeria 16
KE - Kenya 16
LT - Lituania 16
TH - Thailandia 14
TN - Tunisia 14
EG - Egitto 12
CH - Svizzera 11
RO - Romania 11
UY - Uruguay 11
AE - Emirati Arabi Uniti 10
ET - Etiopia 10
IE - Irlanda 10
AL - Albania 9
MU - Mauritius 9
OM - Oman 9
PY - Paraguay 9
NP - Nepal 8
PS - Palestinian Territory 8
TW - Taiwan 8
BO - Bolivia 7
DO - Repubblica Dominicana 7
HR - Croazia 7
LB - Libano 7
BG - Bulgaria 6
CR - Costa Rica 6
CU - Cuba 6
DK - Danimarca 6
JM - Giamaica 6
KG - Kirghizistan 6
KZ - Kazakistan 6
PA - Panama 6
GR - Grecia 5
GT - Guatemala 5
HN - Honduras 5
HU - Ungheria 5
NG - Nigeria 5
PE - Perù 5
RS - Serbia 5
SN - Senegal 5
GA - Gabon 4
GE - Georgia 4
NO - Norvegia 4
PT - Portogallo 4
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
EE - Estonia 3
LA - Repubblica Popolare Democratica del Laos 3
LU - Lussemburgo 3
NZ - Nuova Zelanda 3
SK - Slovacchia (Repubblica Slovacca) 3
BY - Bielorussia 2
CI - Costa d'Avorio 2
KH - Cambogia 2
Totale 444.326
Città #
Cagliari 397.247
Uta 5.912
Fairfield 2.551
Woodbridge 2.154
Ashburn 2.035
Singapore 1.714
Chandler 1.537
Houston 1.412
San Jose 1.190
Wilmington 1.127
Ann Arbor 1.047
Seattle 998
Boardman 920
Jacksonville 891
Dallas 877
Cambridge 854
Nyköping 710
Beijing 624
Helsinki 402
Dearborn 392
Nanjing 355
Los Angeles 320
Lauterbourg 279
Hong Kong 273
Santa Clara 248
Boston 246
The Dalles 246
New York 244
Hefei 240
Shanghai 207
Ho Chi Minh City 204
Buffalo 182
Milan 169
Seoul 167
Hanoi 140
San Diego 131
Shenyang 131
Munich 125
Guangzhou 108
Nanchang 106
Toronto 98
Hebei 90
Redwood City 87
Jiaxing 86
Changsha 85
São Paulo 85
Norwalk 83
Verona 81
London 80
Washington 71
Tianjin 67
Sassari 64
Orem 63
Redondo Beach 60
Council Bluffs 57
Chicago 56
Atlanta 51
Jinan 45
Mountain View 45
Zhengzhou 45
Hangzhou 44
Rome 44
Tokyo 43
Dong Ket 40
Frankfurt am Main 39
Ningbo 37
Warsaw 37
Phoenix 36
Brooklyn 35
Da Nang 34
Columbus 33
Stockholm 32
Auburn Hills 31
Brussels 31
Tashkent 31
Orange 30
Johannesburg 29
Montreal 29
Taizhou 29
Chennai 28
Kunming 28
Pune 28
Rio de Janeiro 28
Haiphong 27
Amsterdam 24
Baghdad 24
Istanbul 24
Nuremberg 24
San Francisco 24
Belo Horizonte 21
Manchester 21
Porto Alegre 21
Curitiba 20
Wuhan 20
Baku 18
Dhaka 18
Falls Church 18
Vienna 18
Brasília 17
Lahore 17
Totale 431.246
Nome #
Natalizumab in aggressive multiple sclerosis after haematopoietic stem cell transplantation 6.157
(1)H-NMR analysis provides a metabolomic profile of patients with multiple sclerosis 5.967
Vitamin D responsive elements within the HLA-DRB1 promoter region in Sardinian multiple sclerosis associated alleles 5.238
Erratum to: Charcot–Marie–Tooth disease: genetic subtypes in the Sardinian population (Neurological Sciences, (2017), 38, 6, (1019-1025), 10.1007/s10072-017-2905-x 4.937
Evaluation of Stroop color word test as cognitive task to investigate cognitive motor interference during walking in Multiple Sclerosis 4.578
EFFECTS OF SIX MONTHS TRAINING ON PHYSICAL CAPACITY AND METABOREFLEX ACTIVITY IN PATIENTS WITH MULTIPLE SCLEROSIS. 4.495
Quantitative assessment of alterations induced by spasticity on gait of individuals with multiple sclerosis using 3D gait analysis 4.485
Is Geo-Environmental Exposure a Risk Factor for Multiple Sclerosis? A Population-Based Cross-Sectional Study in South-Western Sardinia 4.390
Role of interferon-beta in Mycobacterium avium subspecies paratuberculosis antibody response in Sardinian MS patients 4.299
C9ORF72 intermediate repeat expansion in patients affected by atypical Parkinsonian syndromes or parkinson’s disease complicated by psychosis or dementia in a Sardinian population 4.282
The burden of multiple sclerosis variants in continental Italians and Sardinians 4.216
Quantitative assessment of the effects of 6 months of adapted physical activity on gait in people with multiple sclerosis: a randomized controlled trial 4.211
Overexpression of the cytokine BAFF and autoimmunity risk 4.105
Intrathecal oligoclonal bands synthesis in multiple sclerosis: is it always a prognostic factor? 4.036
Assessment of geochemical factors in multiple sclerosis distribution in the South-Western Sardinia 4.011
Mycobacterium avium subsp. Paratuberculosis and multiple sclerosis in Sardinian patients: Epidemiology and clinical features 3.924
What do multiple sclerosis patients and their caregivers perceive as unmet needs? 3.880
Exploring cognitive motor interference in multiple sclerosis by the visual Stroop test 3.837
Clinical Assessment of Gait in Individuals with Multiple Sclerosis Using Wearable Inertial Sensors: Comparison with Patient-Based Measure 3.836
Interaction between HLA-DRB1-DQB1 haplotypes in Sardinian multiple sclerosis population 3.817
Effectiveness and Limitations of Unsupervised Home-Based Balance Rehabilitation with Nintendo Wii in People with Multiple Sclerosis 3.802
Fatigue, as measured using the Modified Fatigue Impact Scale, is a predictor of processing speed improvement induced by exercise in patients with multiple sclerosis: data from a randomized controlled trial 3.731
The Required Coefficient of Friction for evaluating gait alterations in people with Multiple Sclerosis during gait 3.705
Performance in daily activities, cognitive impairment and perception in multiple sclerosis patients and their caregivers 3.661
Walking improvements with nabiximols in patients with multiple sclerosis 3.648
Localized pigmentation disorder after subcutaneous pegylated interferon beta-1a injection 3.616
Quantifying gait impairment in individuals affected by Charcot-Marie-Tooth disease: the usefulness of gait profile score and gait variable score 3.608
Multiple sclerosis and HLA genotypes: A possible influence on brain atrophy 3.586
Factors influencing MS outcome in Sardinia: a clinical and genetic study 3.584
The impact of modifiable risk factors on lesion burden in patients with early multiple sclerosis 3.433
Dynamical insights into the differential characteristics of Mycobacterium avium subsp. paratuberculosis peptide binding to HLA-DRB1 proteins associated with multiple sclerosis 3.413
Impact of brain atrophy on walking in multiple sclerosis patients with low disability: a dual task study. 3.405
Impact of the media on future hope in multiple sclerosis 3.383
Long-term follow-up more than 10 years after HSCT: a monocentric experience 3.313
Association between brain atrophy and cognitive motor interference in multiple sclerosis 3.305
Are static and functional balance abilities related in individuals with Multiple Sclerosis? 3.288
Cardiac involvement in patients with lamin A/C gene mutations: a cohort observation 3.237
A comparison of the brief international cognitive assessment for multiple sclerosis and the brief repeatable battery in multiple sclerosis patients 3.211
Oral agents in multiple sclerosis 3.209
Influence of treatments in multiple sclerosis disability: a cohort study 3.179
A genetic study of the FMR1 gene in a Sardinian multiple sclerosis population 3.111
Metabolomic analysis identifies altered metabolic pathways in Multiple Sclerosis 3.102
Population based study of 12 autoimmune diseases in Sardinia, Italy: prevalence and comorbidity 3.069
An unusual infection in MS patient treated with dimethyl fumarate: A case report of omphalitis 3.055
Brain volume in early MS patients with and without IgG oligoclonal bands in CSF 3.041
Refining the connection between gait and cognition: training the body to improve the brain 2.981
Charcot–Marie–Tooth disease: genetic subtypes in the Sardinian population 2.975
Variants within the immunoregulatory CBLB gene are associated with multiple sclerosis 2.972
Relationship between gait initiation and disability in individuals affected by multiple sclerosis 2.957
Effect of 6 months of adapted physical activity on gait patterns in individuals with multiple sclerosis: a three-dimensional quantitative analysis 2.950
Multiple sclerosis risk: interaction between human leukocyte antigen and the environment in Sardinian population 2.874
Cognition in multiple sclerosis: Between cognitive reserve and brain volume 2.871
Effect of spasticity on kinematics of gait and muscular activation in people with multiple sclerosis 2.809
Structural and dynamical insights on HLA-DR2 complexes that confer susceptibility to multiple sclerosis in Sardinia: a molecular dynamics simulation study 2.724
C9ORF72 repeat expansion and bipolar disorder–is there a link? No mutation detected in a Sardinian cohort of patients with bipolar disorder 2.671
Postural adaptation during a Nintendo Wii balance training 2.668
Perception of risk and shared decision making process in multiple sclerosis 2.652
Smoothness of gait detects early alterations of walking in persons with multiple sclerosis without disability 2.637
Cardiac and muscle imaging findings in a family with X-linked Emery-Dreifuss muscular dystrophy 2.615
Variation within the CLEC16A gene shows consistent disease association with both multiple sclerosis and type 1 diabetes in Sardinia 2.568
Pregnancy outcome in multiple sclerosis women treated with mitoxantrone 2.556
Serum BAFF levels, Methypredsinolone therapy, Epstein-Barr Virus and Mycobacterium avium subsp. paratuberculosis infection in Multiple Sclerosis patients 2.533
Neuroactive steroid levels in plasma and cerebrospinal fluid of male multiple sclerosis patients 2.526
Dopamine dysregulation syndrome in Parkinson's disease patients on levodopa-carbidopa intestinal gel 2.497
Vitamin D serum levels and balance are not related in Multiple Sclerosis 2.443
Genetic loci linked to type 1 diabetes and multiple sclerosis families in Sardinia 2.435
Antigenic epitopes of MAP2694 homologous to T-cell receptor gamma-chain are highly recognized in multiple sclerosis Sardinian patient 2.403
Evaluation of high doses of ascorbic acid efficacy in Charcot Marie Tooth type 1A 2.331
Attitude towards physical activity in patients with multiple sclerosis: a cohort study 2.327
The cohort of the multiple sclerosis center of Cagliari 2.322
Balance patterns in people with multiple sclerosis using Nintendo Wii 2.312
Muscle elastography: a new imaging technique for multiple sclerosis spasticity measurement 2.308
Study of autonomic cardiovascular dysfunction in Parkinson’s disease patients with LRRK2 mutations using Heart Rate Variability 2.303
Evolution of the phenotype in a family with an LMNA gene mutation presenting with isolated cardiac involvement 2.300
Muscle MRI findings in patients with an apparently exclusive cardiac phenotype due to a novel LMNA gene mutation 2.286
Induction and escalation therapies in multiple sclerosis 2.279
Dilated cardiomyopathy with conduction defects in a patient with partial merosin deficiency due to mutations in the laminin-α2-chain gene: a chance association or a novel phenotype? 2.273
Presence of oligoclonal IgG bands in Sardinians with multiple sclerosis is influenced by carriage of different HLA DRB1-DQB1 haplotypes 2.256
Cognitive screening in patients with amyotrophic lateral sclerosis in early stages 2.242
Thyroid antibodies in the CSF of Sardinian multiple sclerosis patients 2.226
Muscle imaging analogies in a cohort of patients with different clinical phenotypes caused by LMNA gene mutations 2.103
Multiple sclerosis and fertilization in vitro with embryo transfer (FIVET): a case report 2.068
Genetic analysis for five LRRK2 mutations in a Sardinian parkinsonian population: Importance of G2019S and R1441C mutations in sporadic Parkinson’s disease patients 2.057
Medulloblastoma induces unusual headache with clinical picture of basilar-type migraine complicated by ischaemic infarcts 2.053
Variation of the myelin oligodendrocyte glycoprotein gene is not primarily associated with multiple sclerosis in the Sardinian population 2.052
Interaction of loci within the HLA region influences multiple sclerosis course in the Sardinian population 2.051
Partial lipodystrophy associated with muscular dystrophy of unknown genetic origin 2.034
Novel Characterization of Gait Impairments in People with Multiple Sclerosis by Means of the Gait Profile Score 2.022
Reversible Pisa syndrome in patients with Parkinson's disease on dopaminergic therapy 2.011
The co-inheritance of type 1 diabetes and multiple sclerosis in Sardinia cannot be explained by genotype variation in the HLA region alone 1.984
Validation of the DYMUS questionnaire for the assessment of dysphagia in multiple sclerosis 1.957
The Italian multiple sclerosis register 1.936
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks 1.934
Lack of evidence for a role of the myelin basic protein gene in multiple sclerosis susceptibility in Sardinian patients 1.917
Genetic and clinical characteristics of skeletal and cardiac muscle in patients with lamin A/C gene mutations 1.912
Heat shock protein 27 R127W mutation: evidence of a continuum between axonal Charcot-Marie-Tooth and distal hereditary motor neuropathy 1.895
Bipolar affective disorder preceding frontotemporal dementia in a patient with C9ORF72 mutation: is there a genetic link between these two disorders? 1.889
Parkin exon rearrangements and sequence variants in LRRK2 mutations carriers: analysis on a possible modifier effects on LRRK2 penetrance 1.884
The risk of bipolar disorders in multiple sclerosis 1.878
Vagal nerve stimulation effects on cerebellar tremor in multiple sclerosis 1.868
Totale 301.983
Categoria #
all - tutte 561.741
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 561.741


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20219.320 0 0 0 0 0 0 0 0 0 0 5.771 3.549
2021/202218.941 2.535 1.435 848 1.601 1.589 1.125 849 946 1.793 1.920 2.294 2.006
2022/202324.683 2.330 3.509 3.302 1.960 1.903 2.566 1.003 2.214 1.458 1.531 1.769 1.138
2023/202425.151 1.707 1.364 903 1.878 2.593 3.911 2.672 2.203 1.249 2.130 2.435 2.106
2024/202566.681 22.110 21.004 7.604 4.023 2.627 2.703 3.648 377 672 643 588 682
2025/202613.994 1.024 696 1.762 1.355 1.167 1.243 2.705 1.193 1.182 1.617 50 0
Totale 445.109